AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 1177.HK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Sino Biopharmaceutical Limited stock still a buy after falling -5.75% on Tuesday?
(Updated on May 21, 2024)

Sell candidate since May 21, 2024 PDF

The Sino Biopharmaceutical Limited stock price fell by -5.75% on the last day (Tuesday, 21st May 2024) from HK$3.13 to HK$2.95. During the last trading day the stock fluctuated 6.51% from a day low at HK$2.92 to a day high of HK$3.11. The price has risen in 5 of the last 10 days and is up by 2.08% over the past 2 weeks. Volume has increased on the last day by 40 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 75 million shares were bought and sold for approximately HK$221.41 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at HK$3.12 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.68% during the next 3 months and, with a 90% probability hold a price between HK$2.04 and HK$2.85 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

1177.HK Signals & Forecast

The Sino Biopharmaceutical Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately HK$3.07. On a fall, the stock will find some support from the long-term average at approximately HK$2.83. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 20, 2024, and so far it has fallen -5.75%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Sino Biopharmaceutical Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at HK$2.68 and HK$2.54. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Sino Biopharmaceutical Limited finds support just below today's level at HK$2.68. If this is broken, then the next support from accumulated volume will be at HK$2.54 and HK$2.34.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved HK$0.190 between high and low, or 6.51%. For the last week, the stock has had daily average volatility of 3.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (1177.HK) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Sino Biopharmaceutical Limited to open at HK$2.99, and during the day (based on 14 day Average True Range), to move between HK$2.83 and HK$3.07, which gives a possible trading interval of +/-HK$0.124 (+/-4.20%) up or down from last closing price. If Sino Biopharmaceutical Limited takes out the full calculated possible swing range there will be an estimated 8.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$3.06 (3.73%) than the support at HK$2.68 (9.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sino Biopharmaceutical Limited stock A Buy?

Sino Biopharmaceutical Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.850 Sell Candidate Downgraded

Predicted Opening Price for Sino Biopharmaceutical Limited of Wednesday, May 22, 2024

Fair opening price May 22, 2024 Current price
HK$2.99 ( 1.47%) HK$2.95

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 1177.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.18 7.91 %
R2 3.11 5.45 %
R1 3.07 3.93 %
Current price: 2.95
Support S1 2.92 -0.99 %
S2 2.88 -2.51 %
S3 2.80 -4.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.15 6.78 %
R2 3.11 5.42 %
R1 3.06 3.73 %
Current price 2.95
Support S1 2.68 -9.15%
S2 2.54 -13.90%
S3 2.34 -20.68%

1177 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 11, 2024 Jun 11, 2024 Jul 05, 2024 HK$0.0300 1.02%
2 Jun 20, 2023 Jun 20, 2023 Jun 20, 2023 HK$0.0600 1.62%
3 Sep 06, 2022 Sep 06, 2022 Sep 06, 2022 HK$0.0600 1.53%
4 Jun 15, 2022 Jun 15, 2022 Jun 15, 2022 HK$0.0400 0.96%
5 Sep 13, 2021 Sep 13, 2021 Sep 13, 2021 HK$0.0200 0.298%

FAQ

What is the symbol for Sino Biopharmaceutical Limited Stock and on which exchange is it traded?
The symbol for Sino Biopharmaceutical Limited is 1177.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Sino Biopharmaceutical Limited Stock?
Sino Biopharmaceutical Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Sino Biopharmaceutical Limited Stock?
Sino Biopharmaceutical Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sino Biopharmaceutical Limited Stock.

What's the current price of Sino Biopharmaceutical Limited Stock?
As of the end of day on the May 21, 2024, the price of an Sino Biopharmaceutical Limited (1177.HK) share was HK$2.95.

What is the 52-week high and low for Sino Biopharmaceutical Limited Stock?
The 52-week high for Sino Biopharmaceutical Limited Stock is HK$4.07 and the 52-week low is HK$2.29.

What is the market capitalization of Sino Biopharmaceutical Limited Stock?
As of the May 21, 2024, the market capitalization of Sino Biopharmaceutical Limited is 57.426B.

When is the next earnings date for Sino Biopharmaceutical Limited?
The upcoming earnings date for Sino Biopharmaceutical Limited is Jun 05, 2024.
Click to get the best stock tips daily for free!

About Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; ... 1177.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT